American Trust’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,020
Closed -$431K 271
2024
Q2
$431K Sell
5,020
-2,380
-32% -$200K 0.04% 136
2024
Q1
$611K Sell
7,400
-8
-0.1% -$586 0.05% 130
2023
Q4
$494K Buy
7,408
+3,738
+102% +$242K 0.04% 143
2023
Q3
$246K Buy
+3,670
New +$252K 0.02% 238
2022
Q3
Sell
-5,708
Closed -$255K 434
2022
Q2
$255K Hold
5,708
0.02% 350
2022
Q1
$323K Hold
5,708
0.02% 334
2021
Q4
$296K Buy
+5,708
New +$294K 0.02% 241

Other funds holding EHC

American Trust's EHC Position: Q3 2024 in Review

American Trust sold out of Encompass Health (EHC) in Q3 2024, closing a stake of 5,020 shares — an estimated $431K sold.

American Trust first reported a position in EHC in Q4 2021 and held it in 7 quarters. The position peaked at $611K in Q1 2024. 482 funds tracked by Wall St. Rank hold EHC as of Q3 2024.

  • American Trust reported no remaining Encompass Health position as of Q3 2024 after selling out during the quarter.
  • American Trust sold 5,020 Encompass Health shares in Q3 2024, an estimated $431K.
  • American Trust first reported a position in Encompass Health in Q4 2021 and held it in 7 quarters.
  • American Trust's Encompass Health position peaked at $611K in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Encompass Health as of Q3 2024.

Based on American Trust's 13F filing for Q3 2024, filed 29 Nov 2024.